Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

被引：0
|
作者：
Chiao-En Wu
Ching-Fu Chang
Chen-Yang Huang
Cheng-Ta Yang
Chih-Hsi Scott Kuo
Ping-Chih Hsu
John Wen-Cheng Chang
机构：
[1] Chang Gung University College of Medicine,Department of Internal Medicine, Division of Hematology
[2] Chang Gung University College of Medicine,Oncology, Chang Gung Memorial Hospital at Linkou
来源：
BMC Cancer | / 21卷
关键词：
Lung cancer; Afatinib; EGFR; TKI; Performance status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study
    Wu, Chiao-En
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    [J]. BMC CANCER, 2021, 21 (01)
  • [2] Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
    Codony-Servat, Jordi
    Codony-Servat, Caries
    Cardona, Andres Felipe
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Berenguer, Ordi
    Paulina Bracht, Milan Wilhe Mina
    Ito, Masaoki
    Karachaliou, Niki
    Rosell, Rafael
    [J]. CLINICAL LUNG CANCER, 2019, 20 (03) : 167 - 177
  • [3] Efficacy of afatinib following osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
    Tamura, Tomohiro
    Okubo, Hatsumi
    Yamada, Yutaka
    Kikkawa, Yasuko
    Yamaguchi, Shozaburo
    Hashimoto, Ikuta
    Kaburagi, Takayuki
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S335 - S335
  • [4] Analysis of Survival in EGFR-Mutation-Positive Advanced Non-Small-Cell Lung Cancer Patients with Miliary Pulmonary Metastasis
    Watanabe, Kageaki
    Okuma, Yusuke
    Miwa, Maki
    Hosomi, Yukio
    Okamura, Tatsuru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1228 - S1229
  • [5] Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study
    Hochmair, Maximilian J.
    Morabito, Alessandro
    Hao, Desiree
    Yang, Cheng-Ta
    Soo, Ross A.
    Yang, James C-H
    Gucalp, Rasim
    Halmos, Balazs
    Wang, Lara
    Golembesky, Amanda
    Maerten, Angela
    Cufer, Tanja
    [J]. FUTURE ONCOLOGY, 2018, 14 (27) : 2861 - 2874
  • [6] Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status
    Nakashima, Kazuhisa
    Kimura, Madoka
    Akamatsu, Hiroaki
    Daga, Haruko
    Imai, Hisao
    Taira, Tetsuhiko
    Ko, Ryo
    Hisamatsu, Yasushi
    Nishino, Kazumi
    Sugimoto, Takeya
    Miyashita, Yosuke
    Takahashi, Toshiaki
    Kumagai, Toru
    Yamamoto, Nobuyuki
    Murakami, Haruyasu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (07) : 671 - 675
  • [7] The Impact of CNS Recurrence on Post-recurrence Survival in Patients with EGFR-mutation-positive Non-small-cell Lung Cancer
    Okamoto, T.
    Takenaka, T.
    Yamazaki, K.
    Hamatake, M.
    Miura, N.
    Takenoyama, M.
    Kometani, T.
    Ueda, H.
    Kouso, H.
    Yano, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S471 - S472
  • [8] Afatinib in EGFR mutation positive advanced non-small cell lung cancer
    Davies, R. S.
    Brewster, A. E.
    Button, M. R.
    Lester, J. F.
    [J]. LUNG CANCER, 2016, 91 : S22 - S22
  • [9] Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
    Paulina Bracht, Jillian Wilhelmina
    Karachaliou, Niki
    Berenguer, Jordi
    Pedraz-Valdunciel, Carlos
    Filipska, Martyna
    Codony-Servat, Carles
    Codony-Servat, Jordi
    Rosell, Rafael
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12): : 2607 - 2614
  • [10] Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag study
    Hochmair, Maximilian J.
    Morabito, Alessandro
    Hao, Desiree
    Yang, Cheng-Ta
    Soo, Ross A.
    Yang, James C-H
    Gucalp, Rasim
    Halmos, Balazs
    Wang, Lara
    Maerten, Angela
    Cufer, Tanja
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2905 - 2913
12345